Old Web
English
Sign In
Acemap
>
Paper
>
Tocilizumab in COVID-19 therapy: who benefits, and how? - Authors' reply.
Tocilizumab in COVID-19 therapy: who benefits, and how? - Authors' reply.
2021
Peter Horby
Natalie Staplin
Richard Haynes
Martin J. Landray
Keywords:
Monoclonal
Tocilizumab
2019 20 coronavirus outbreak
Coronavirus disease 2019
Medicine
Virology
severe acute respiratory syndrome coronavirus 2
Correction
Source
Cite
Save
Machine Reading By IdeaReader
2
References
1
Citations
NaN
KQI
[]